[EN] PREGNANOLONE DERIVATIVES SUBSTITUTED IN 3ALPHA-POSITION WITH THE CATIONIC GROUP, METHOD OF THEIR PRODUCTION, USAGE AND PHARMACEUTICAL PREPARATION INVOLVING THEM<br/>[FR] DÉRIVÉS DE LA PRÉGNANOLONE, SUBSTITUÉS EN POSITION 3 ALPHA PAR LE GROUPE CATIONIQUE, PROCÉDÉS DE PRODUCTION ET D'UTILISATION ASSOCIÉS, ET PRÉPARATIONS PHARMACEUTIQUES LES CONTENANT
申请人:USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY V V I
公开号:WO2012110010A1
公开(公告)日:2012-08-23
The presented invention applies to pregnanolone derivatives, substituted in 3 alpha-position with the cationic group, of general formula I, the method of the production of these compounds and their utilization for treatment of neuropsychiatric disorders related to imbalance of glutamatergic neurotransmitter system, such as ischemic damage of CNS, neurodegenerative changes and disorders of CNS, affective disorders, depression, post traumatic stress dissorder, and other diseases related to stress, anxiety, schizophrenia, and psychotic disorders, pain, addictions, multiple sclerosis, epilepsy, and gliomas. The object of invention is also the use of compounds of general formula I for production of veterinary and human pharmaceutical preparation for treatment of above mentioned diseases and for production of pharmaceutical preparations containing these compounds.
该发明涉及孕酮醇衍生物,其在3α位被带正电荷的基团取代,其一般化学式为I,以及这些化合物的生产方法和它们用于治疗与谷氨酸能神经递质系统失衡相关的神经精神障碍,如中枢神经系统的缺血损伤、神经退行性变化和中枢神经系统障碍、情感障碍、抑郁症、创伤后应激障碍以及其他与压力、焦虑、精神分裂症和精神障碍、疼痛、成瘾、多发性硬化、癫痫和胶质瘤相关的疾病的治疗。该发明的目的还包括将一般化学式I的化合物用于制备用于治疗上述疾病的兽药和人类药物制剂,以及用于制备含有这些化合物的药物制剂。